T. Rowe Price Associates
NTUS

T. Rowe Price Associates’s Natus Medical Inc NTUS Stock Holding History

T. Rowe Price Associates’s Portfolio NTUS Stock Details NTUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-19,756
Closed -$431K – 2643
2020
Q2 		$431K Buy
19,756
+2,726
+16% +$62.4K ﹤0.01% 2109
2020
Q1 		$394K Buy
17,030
+202
+1% +$5.87K ﹤0.01% 2092
2019
Q4 		$555K Buy
16,828
+1,337
+9% +$42.8K ﹤0.01% 2117
2019
Q3 		$493K Buy
15,491
+171
+1% +$4.98K ﹤0.01% 2109
2019
Q2 		$394K Sell
15,320
-228,175
-94% -$5.81M ﹤0.01% 2209
2019
Q1 		$6.18M Sell
243,495
-113,146
-32% -$3.38M ﹤0.01% 1380
2018
Q4 		$12.1M Sell
356,641
-10,593
-3% -$344K ﹤0.01% 1279
2018
Q3 		$13.1M Buy
367,234
+58,885
+19% +$2.08M ﹤0.01% 1329
2018
Q2 		$10.6M Buy
308,349
+39,340
+15% +$1.38M ﹤0.01% 1334
2018
Q1 		$9.05M Sell
269,009
-128,076
-32% -$4.05M ﹤0.01% 1354
2017
Q4 		$15.2M Sell
397,085
-91,401
-19% -$3.65M ﹤0.01% 1265
2017
Q3 		$18.3M Buy
488,486
+27,993
+6% +$988K ﹤0.01% 1212
2017
Q2 		$17.2M Buy
460,493
+33,483
+8% +$1.21M ﹤0.01% 1218
2017
Q1 		$16.8M Buy
427,010
+14,080
+3% +$528K ﹤0.01% 1227
2016
Q4 		$14.4M Sell
412,930
-450
-0.1% -$17.7K ﹤0.01% 1236
2016
Q3 		$16.2M Buy
413,380
+37,800
+10% +$1.51M ﹤0.01% 1200
2016
Q2 		$14.2M Buy
375,580
+10,450
+3% +$350K ﹤0.01% 1209
2016
Q1 		$14M Buy
365,130
+21,640
+6% +$806K ﹤0.01% 1186
2015
Q4 		$16.5M Buy
343,490
+64,990
+23% +$3.01M ﹤0.01% 1147
2015
Q3 		$11M Buy
278,500
+93,700
+51% +$3.98M ﹤0.01% 1289
2015
Q2 		$7.87M Buy
+184,800
New +$7.36M ﹤0.01% 1399

Other funds holding NTUS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

T. Rowe Price Associates's NTUS Position: Q3 2020 in Review

T. Rowe Price Associates sold out of Natus Medical Inc (NTUS) in Q3 2020, closing a stake of 19,756 shares — an estimated $431K sold.

T. Rowe Price Associates first reported a position in NTUS in Q2 2015 and held it in 21 quarters. The position peaked at $18.3M in Q3 2017. 159 funds tracked by Wall St. Rank hold NTUS as of Q3 2020.

  • T. Rowe Price Associates reported no remaining Natus Medical Inc position as of Q3 2020 after selling out during the quarter.
  • T. Rowe Price Associates sold 19,756 Natus Medical Inc shares in Q3 2020, an estimated $431K.
  • T. Rowe Price Associates first reported a position in Natus Medical Inc in Q2 2015 and held it in 21 quarters.
  • T. Rowe Price Associates's Natus Medical Inc position peaked at $18.3M in Q3 2017.
  • 159 funds tracked by Wall St. Rank held Natus Medical Inc as of Q3 2020.

Based on T. Rowe Price Associates's 13F filing for Q3 2020, filed 16 Nov 2020.